{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:29:44Z","timestamp":1793827784708,"version":"4.6.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02192-y","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T10:20:10Z","timestamp":1770459610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Spatial transcriptomics identifies IL-32 as a lipid droplet-associated cytokine linked to tubular injury in human diabetic kidney disease"],"prefix":"10.1007","volume":"75","author":[{"given":"Kieran","family":"Meadows","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjae","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Son","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysa","family":"Imanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heewon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisay Getie","family":"Belay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Swamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulin","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andonegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallgrimur","family":"Benediktsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Stys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thang","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Muruve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"2192_CR1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2192_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ncpendmet0894","volume":"4","author":"S Dronavalli","year":"2008","unstructured":"Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab. 2008;4:444\u201352.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2192_CR3","doi-asserted-by":"publisher","first-page":"F831","DOI":"10.1152\/ajprenal.00313.2016","volume":"311","author":"CB Marshall","year":"2016","unstructured":"Marshall CB. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic? Am J Physiol Renal Physiol. 2016;311:F831\u201343.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2192_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00422326","volume":"11","author":"R Osterby","year":"1975","unstructured":"Osterby R, Gundersen HJ. Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia. 1975;11:225\u20139.","journal-title":"Diabetologia"},{"key":"2192_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2337\/diab.38.9.1077","volume":"38","author":"MW Steffes","year":"1989","unstructured":"Steffes MW, Osterby R, Chavers B, Mauer SM. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes. 1989;38:1077\u201381.","journal-title":"Diabetes"},{"key":"2192_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21:556\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"2192_CR7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00125-018-4567-5","volume":"61","author":"HM Colhoun","year":"2018","unstructured":"Colhoun HM, Marcovecchio ML. Biomarkers of diabetic kidney disease. Diabetologia. 2018;61:996\u20131011.","journal-title":"Diabetologia"},{"key":"2192_CR8","doi-asserted-by":"crossref","unstructured":"Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P, Susztak K. Molecular pathways that drive diabetic kidney disease. The Journal of clinical investigation 2023; 133.","DOI":"10.1172\/JCI165654"},{"key":"2192_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coph.2020.09.004","volume":"55","author":"A Mitrofanova","year":"2020","unstructured":"Mitrofanova A, Fontanella AM, Merscher S, Fornoni A. Lipid deposition and metaflammation in diabetic kidney disease. Curr Opin Pharmacol. 2020;55:60\u201372.","journal-title":"Curr Opin Pharmacol"},{"key":"2192_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1194\/jlr.P040501","volume":"55","author":"M Herman-Edelstein","year":"2014","unstructured":"Herman-Edelstein M, Scherzer P, Tobar A, Levi M, Gafter U. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res. 2014;55:561\u201372.","journal-title":"J Lipid Res"},{"issue":"83\u201398","key":"2192_CR11","first-page":"7","volume":"12","author":"P Kimmelstiel","year":"1936","unstructured":"Kimmelstiel P, Wilson C. Intercapillary Lesions in the Glomeruli of the Kidney. Am J Pathol. 1936;12(83\u201398):7.","journal-title":"Am J Pathol"},{"key":"2192_CR12","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1042\/CS20180702","volume":"132","author":"W Yang","year":"2018","unstructured":"Yang W, Luo Y, Yang S, Zeng M, Zhang S, Liu J, et al. Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease. Clin Sci (Lond). 2018;132:2407\u201322.","journal-title":"Clin Sci (Lond)"},{"key":"2192_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","volume":"2","author":"JF Moorhead","year":"1982","unstructured":"Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2:1309\u201311.","journal-title":"Lancet"},{"key":"2192_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19:629\u201345.","journal-title":"Nat Rev Nephrol"},{"key":"2192_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41574-023-00845-0","volume":"19","author":"A Zadoorian","year":"2023","unstructured":"Zadoorian A, Du X, Yang H. Lipid droplet biogenesis and functions in health and disease. Nat Rev Endocrinol. 2023;19:443\u201359.","journal-title":"Nat Rev Endocrinol"},{"key":"2192_CR16","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1172\/JCI45161","volume":"121","author":"JV Bonventre","year":"2011","unstructured":"Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121:4210\u201321.","journal-title":"J Clin Invest"},{"key":"2192_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med. 2015;21:37\u201346.","journal-title":"Nat Med"},{"key":"2192_CR18","doi-asserted-by":"crossref","unstructured":"Petan T, Jarc E, Jusovic M. Lipid Droplets in Cancer: Guardians of Fat in a Stressful World. Molecules 2018; 23.","DOI":"10.3390\/molecules23081941"},{"key":"2192_CR19","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1194\/jlr.M003525","volume":"51","author":"C Tang","year":"2010","unstructured":"Tang C, Kanter JE, Bornfeldt KE, Leboeuf RC, Oram JF. Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys. J Lipid Res. 2010;51:1719\u201328.","journal-title":"J Lipid Res"},{"key":"2192_CR20","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.2337\/diabetes.54.8.2328","volume":"54","author":"Z Wang","year":"2005","unstructured":"Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb\/db mice with type 2 diabetes. Diabetes. 2005;54:2328\u201335.","journal-title":"Diabetes"},{"key":"2192_CR21","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.2337\/db05-0603","volume":"55","author":"G Proctor","year":"2006","unstructured":"Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes. 2006;55:2502\u20139.","journal-title":"Diabetes"},{"key":"2192_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4239\/wjd.v12.i5.524","volume":"12","author":"A Mitrofanova","year":"2021","unstructured":"Mitrofanova A, Burke G, Merscher S, Fornoni A. New insights into renal lipid dysmetabolism in diabetic kidney disease. World J Diabetes. 2021;12:524\u201340.","journal-title":"World J Diabetes"},{"key":"2192_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10584-4","volume":"10","author":"A Mitrofanova","year":"2019","unstructured":"Mitrofanova A, Mallela SK, Ducasa GM, Yoo TH, Rosenfeld-Gur E, Zelnik ID, et al. SMPDL3b modulates insulin receptor signaling in diabetic kidney disease. Nat Commun. 2019;10:2692.","journal-title":"Nat Commun"},{"key":"2192_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142291","volume":"10","author":"C Martinez-Garcia","year":"2015","unstructured":"Martinez-Garcia C, Izquierdo-Lahuerta A, Vivas Y, Velasco I, Yeo TK, Chen S, et al. Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes. PLoS ONE. 2015;10:e0142291.","journal-title":"PLoS ONE"},{"key":"2192_CR25","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1172\/JCI125316","volume":"129","author":"GM Ducasa","year":"2019","unstructured":"Ducasa GM, Mitrofanova A, Mallela SK, Liu X, Molina J, Sloan A, et al. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes. J Clin Invest. 2019;129:3387\u2013400.","journal-title":"J Clin Invest"},{"key":"2192_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cmet.2017.01.004","volume":"25","author":"A Falkevall","year":"2017","unstructured":"Falkevall A, Mehlem A, Palombo I, Heller Sahlgren B, Ebarasi L, He L, et al. Reducing VEGF-B signaling ameliorates renal lipotoxicity and protects against diabetic kidney disease. Cell Metab. 2017;25:713\u201326.","journal-title":"Cell Metab"},{"key":"2192_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.kint.2024.11.026","volume":"107","author":"E Folestad","year":"2025","unstructured":"Folestad E, Mehlem A, Ning FC, Oosterveld T, Palombo I, Singh J, et al. Vascular endothelial growth factor B-mediated fatty acid flux in the adipose-kidney axis contributes to lipotoxicity in diabetic kidney disease. Kidney Int. 2025;107:492\u2013507.","journal-title":"Kidney Int"},{"key":"2192_CR28","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.2337\/db13-0399","volume":"62","author":"S Merscher-Gomez","year":"2013","unstructured":"Merscher-Gomez S, Guzman J, Pedigo CE, Lehto M, Aguillon-Prada R, Mendez A, et al. Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes. 2013;62:3817\u201327.","journal-title":"Diabetes"},{"key":"2192_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.751529","volume":"8","author":"H Wang","year":"2021","unstructured":"Wang H, Zhang S, Guo J. Lipotoxic proximal tubular injury: a primary event in diabetic kidney disease. Front Med. 2021;8:751529.","journal-title":"Front Med"},{"key":"2192_CR30","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","volume":"33","author":"Y Mori","year":"2021","unstructured":"Mori Y, Ajay AK, Chang JH, Mou S, Zhao H, Kishi S, et al. KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. Cell Metab. 2021;33:1042-1061 e7.","journal-title":"Cell Metab"},{"key":"2192_CR31","doi-asserted-by":"crossref","unstructured":"Elias EE, Lau A, Belay SG, Derakhshani A, Andonegui G, Jenne CN, et al. The spleen tyrosine kinase inhibitor entospletinib resolves inflammation to promote repair following acute kidney injury. JCI Insight 2025; 10.","DOI":"10.1172\/jci.insight.189601"},{"key":"2192_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","volume":"38","author":"CR Merritt","year":"2020","unstructured":"Merritt CR, Ong GT, Church SE, Barker K, Danaher P, Geiss G, et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat Biotechnol. 2020;38:586\u201399.","journal-title":"Nat Biotechnol"},{"key":"2192_CR33","doi-asserted-by":"crossref","unstructured":"Vo S, Meadows K, Do H, Chapman K, Andonegui G, Muruve DA, et al. Streamlining single-cell spatial transcriptomics for human kidney tissue. Biotechniques 2025:1\u201314.","DOI":"10.1101\/2025.09.02.673834"},{"key":"2192_CR34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41592-018-0229-2","volume":"15","author":"R Lopez","year":"2018","unstructured":"Lopez R, Regier J, Cole MB, Jordan MI, Yosef N. Deep generative modeling for single-cell transcriptomics. Nat Methods. 2018;15:1053\u20138.","journal-title":"Nat Methods"},{"key":"2192_CR35","unstructured":"McInnes L, Healy J, Melville J. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction. arXIV 2020."},{"key":"2192_CR36","unstructured":"Buitinck L, Louppe G, Blondel M, Pedregosa F, Mueller A, Grisel O, et al. API design for machine learning software: experiences from hte scikit-learn project. arXIV 2013."},{"key":"2192_CR37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1083\/jcb.100.3.965","volume":"100","author":"P Greenspan","year":"1985","unstructured":"Greenspan P, Mayer EP, Fowler SD. Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol. 1985;100:965\u201373.","journal-title":"J Cell Biol"},{"key":"2192_CR38","first-page":"2688","volume":"2021","author":"A Kline","year":"2021","unstructured":"Kline A, Chung HJ, Rahmani W, Chun J. Semi-supervised segmentation of renal pathology: an alternative to manual segmentation and input to deep learning training. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:2688\u201391.","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"2192_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.devcel.2017.11.020","volume":"44","author":"K Bersuker","year":"2018","unstructured":"Bersuker K, Peterson CWH, To M, Sahl SJ, Savikhin V, Grossman EA, et al. A proximity labeling strategy provides insights into the composition and dynamics of lipid droplet proteomes. Dev Cell. 2018;44:97-112.e7.","journal-title":"Dev Cell"},{"key":"2192_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154832","volume":"125","author":"R Fadaei","year":"2020","unstructured":"Fadaei R, Bagheri N, Heidarian E, Nouri A, Hesari Z, Moradi N, et al. Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-\u03b1 and IL-6. Cytokine. 2020;125:154832.","journal-title":"Cytokine"},{"key":"2192_CR41","doi-asserted-by":"publisher","first-page":"15874","DOI":"10.1073\/pnas.2005477117","volume":"117","author":"Y Kirita","year":"2020","unstructured":"Kirita Y, Wu H, Uchimura K, Wilson PC, Humphreys BD. Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury. Proc Natl Acad Sci U S A. 2020;117:15874\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2192_CR42","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-024-01802-x","volume":"56","author":"A Abedini","year":"2024","unstructured":"Abedini A, Levinsohn J, Kl\u00f6tzer KA, Dumoulin B, Ma Z, Frederick J, et al. Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression. Nat Genet. 2024;56:1712\u201324.","journal-title":"Nat Genet"},{"key":"2192_CR43","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","volume":"273","author":"T Ichimura","year":"1998","unstructured":"Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273:4135\u201342.","journal-title":"J Biol Chem"},{"key":"2192_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32972-z","volume":"13","author":"PC Wilson","year":"2022","unstructured":"Wilson PC, Muto Y, Wu H, Karihaloo A, Waikar SS, Humphreys BD. Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression. Nat Commun. 2022;13:5253.","journal-title":"Nat Commun"},{"key":"2192_CR45","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","volume":"619","author":"BB Lake","year":"2023","unstructured":"Lake BB, Menon R, Winfree S, Hu Q, Melo Ferreira R, Kalhor K, et al. An atlas of healthy and injured cell states and niches in the human kidney. Nature. 2023;619:585\u201394.","journal-title":"Nature"},{"key":"2192_CR46","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/db10-1181","volume":"60","author":"KI Woroniecka","year":"2011","unstructured":"Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K. Transcriptome analysis of human diabetic kidney disease. Diabetes. 2011;60:2354\u201369.","journal-title":"Diabetes"},{"key":"2192_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","volume":"148","author":"CA Dahl","year":"1992","unstructured":"Dahl CA, Schall RP, He HL, Cairns JS. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol. 1992;148:597\u2013603.","journal-title":"J Immunol"},{"key":"2192_CR48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.biochi.2014.01.013","volume":"101","author":"J-W Kang","year":"2014","unstructured":"Kang J-W, Park YS, Lee DH, Kim MS, Bak Y, Ham SY, et al. Interaction network mapping among IL-32 isoforms. Biochimie. 2014;101:248\u201351.","journal-title":"Biochimie"},{"key":"2192_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","volume":"126","author":"JD Choi","year":"2009","unstructured":"Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, et al. Identification of the most active interleukin-32 isoform. Immunology. 2009;126:535\u201342.","journal-title":"Immunology"},{"key":"2192_CR50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-020-02218-8","volume":"22","author":"P Di Benedetto","year":"2020","unstructured":"Di Benedetto P, Guggino G, Manzi G, Ruscitti P, Berardicurti O, Panzera N, et al. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension. Arthritis Res Ther. 2020;22:127.","journal-title":"Arthritis Res Ther"},{"key":"2192_CR51","doi-asserted-by":"crossref","unstructured":"Baselli GA, Dongiovanni P, Rametta R, Meroni M, Pelusi S, Maggioni M, et al. Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. 2020; 69:1855\u20131866.","DOI":"10.1136\/gutjnl-2019-319226"},{"key":"2192_CR52","doi-asserted-by":"publisher","first-page":"14050","DOI":"10.1038\/s41598-018-32485-0","volume":"8","author":"MSMA Damen","year":"2018","unstructured":"Damen MSMA, Schraa K, Tweehuysen L, den Broeder AA, Netea MG, Popa CD, et al. Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients. Sci Rep. 2018;8:14050.","journal-title":"Sci Rep"},{"key":"2192_CR53","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1073\/pnas.1016005108","volume":"108","author":"B Heinhuis","year":"2011","unstructured":"Heinhuis B, Koenders MI, van de Loo FA, Netea MG, van den Berg WB, Joosten LA. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis. Proc Natl Acad Sci USA. 2011;108:4962\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2192_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2017.07.005","volume":"264","author":"M Damen","year":"2017","unstructured":"Damen M, Popa CD, Netea MG, Dinarello CA, Joosten LAB. Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases. Atherosclerosis. 2017;264:83\u201391.","journal-title":"Atherosclerosis"},{"key":"2192_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101352","volume":"5","author":"K Sasidharan","year":"2024","unstructured":"Sasidharan K, Caddeo A, Jamialahmadi O, Noto FR, Tomasi M, Malvestiti F, et al. IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids. Cell Rep Med. 2024;5:101352.","journal-title":"Cell Rep Med"},{"key":"2192_CR56","doi-asserted-by":"crossref","unstructured":"Aass KR, Mjelle R, Kastnes MH, Tryggestad SS, van den Brink LM, Aass Roseth I, et al. Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells. iScience 2022; 25:103605.","DOI":"10.1016\/j.isci.2021.103605"},{"key":"2192_CR57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/JLB.3MR0620-550R","volume":"109","author":"KR Aass","year":"2021","unstructured":"Aass KR, Kastnes MH, Standal T. Molecular interactions and functions of IL-32. J Leukoc Biol. 2021;109:143\u201359.","journal-title":"J Leukoc Biol"},{"key":"2192_CR58","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005;22:131\u201342.","journal-title":"Immunity"},{"key":"2192_CR59","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","volume":"442","author":"S Wen","year":"2019","unstructured":"Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M, et al. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23-p38 MAPK signalling. Cancer Lett. 2019;442:320\u201332.","journal-title":"Cancer Lett"},{"key":"2192_CR60","doi-asserted-by":"publisher","unstructured":"Sun Y, Qian Y, Chen C, Wang H, Zhou X, Zhai W, et al. Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK\/STAT3 pathway. J Exp Clin Cancer Res 2022;41:145. https:\/\/doi.org\/10.1186\/s13046-022-02348-8","DOI":"10.1186\/s13046-022-02348-8"},{"key":"2192_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2010.09.002","volume":"53","author":"H Hasegawa","year":"2011","unstructured":"Hasegawa H, Thomas HJ, Schooley K, Born TL. Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein. Cytokine. 2011;53:74\u201383.","journal-title":"Cytokine"},{"key":"2192_CR62","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/bloodadvances.2017010801","volume":"1","author":"M Zahoor","year":"2017","unstructured":"Zahoor M, Westhrin M, Aass KR, Moen SH, Misund K, Psonka-Antonczyk KM, et al. Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss. Blood Adv. 2017;1:2656\u201366.","journal-title":"Blood Adv"},{"key":"2192_CR63","doi-asserted-by":"publisher","unstructured":"Leng K, Rooney B, McCarthy F, Xia W, Rose IVL, Bax S, et al. mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes. J Neuroinflammation 2024;21:198. https:\/\/doi.org\/10.1186\/s12974-024-03165-w","DOI":"10.1186\/s12974-024-03165-w"},{"key":"2192_CR64","doi-asserted-by":"crossref","unstructured":"Khafizov R, Piazza E, Cui Y, Patrick M, Metzger E, McGuire D, et al. Sub-cellular Imaging of the Entire Protein-Coding Human Transcriptome (18933-plex) on FFPE Tissue Using Spatial Molecular Imaging. bioRxiv 2024:2024.11.27.625536.","DOI":"10.1101\/2024.11.27.625536"},{"key":"2192_CR65","doi-asserted-by":"publisher","first-page":"6466","DOI":"10.1158\/1538-7445.AM2025-6466","volume":"85","author":"A Kulasinghe","year":"2025","unstructured":"Kulasinghe A, Kang C, Sato H, Filanoski B, Hamanishi L, Heck A, et al. Abstract 6466: discovery proteome and whole transcriptome atlas analysis of skin cancer reveals biomarkers associated with immunotherapy response and resistance. Cancer Res. 2025;85:6466\u20136466.","journal-title":"Cancer Res"},{"key":"2192_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104449","volume":"371","author":"RS Gomes","year":"2022","unstructured":"Gomes RS, Silva MVT, Oliveira MAP, Joosten LAB, Ribeiro-Dias F. Protective immune response mediated by neutrophils in experimental visceral leishmaniasis is enhanced by IL-32gamma. Cell Immunol. 2022;371:104449.","journal-title":"Cell Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02192-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02192-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02192-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:02:45Z","timestamp":1770465765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02192-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2192"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02192-y","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"33"}}